Carpal Tunnel Syndrome
Conditions
Brief summary
The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.
Detailed description
A total of 46 patients, aged 18-65, diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies, will be included in the study.Pain levels will be assessed using the Visual Analog Scale (VAS), and functional impairment will be measured with the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological evaluations will be performed by a neurology specialist at the 1st and 3rd month follow-ups outside of working hours and without being billed to the Social Security Institution (SGK). VAS, BCTQ scores, and electrophysiological parameters will be evaluated at baseline, and at the 4th and 12th-week follow-ups post-treatment. Electrophysiological measurements will include median nerve distal motor latency (MMNDL), median nerve distal sensory latency (MNSDL), sensory nerve conduction velocity (SNCV), compound muscle action potential (CMAP), and sensory nerve action potential (SNAP) amplitudes.
Interventions
OTHERNo intervention
No intervention
Sponsors
Beylikduzu State Hospital
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Inclusion criteria
* Patients aged 18-65. * Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies. * Received either ultrasound-guided corticosteroid injection or paraffin therapy. * Symptoms persisting for at least 3 months.
Exclusion criteria
* Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome). * History of previous injection or surgery for carpal tunnel syndrome.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale (VAS): | 0 day, 4th week and 12th week | The VAS will be used to measure pain intensity. Patients will mark their pain level on a 10 cm scale, where 0 represents no pain and 10 represents the worst imaginable pain. This will be evaluated at baseline, and at the 4th and 12th weeks post-treatment. |
| Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS) | 0 day, 4th week and 12th week | The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life. |
| Boston Carpal Tunnel Syndrome Questionnaire Functional Status Scale (BCTQ-FSS) | 0 day, 4th week and 12th week | The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Motor nerve conduction velocity | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
| Median nerve distal motor latency | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
| Motor nerve action potential amplitude | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
| Sensory nerve action potential amplitude | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
| Median nerve distal sensory latency | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
| Sensory nerve conduction velocity | 0 day, 4th week and 12th week | It is a finding from electrophysiological evaluation |
Countries
Turkey (Türkiye)
Contacts
Primary ContactBüşra Şirin Ahısha, MD
Backup ContactBüşra Şirin Ahısha
Outcome results
None listed